Cargando…

Low-intensity ultrasound enhances the chemosensitivity of hepatocellular carcinoma cells to cisplatin via altering the miR-34a/c-Met axis

Recently, the use of low-intensity ultrasound (LIUS) combined with chemotherapeutic agents is widely used in clinical practice, mainly for the treatment of cancer; however, the mechanisms as to how LIUS enhances the antitumor effects of these agents are not fully understood. The aim of the present s...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Panpan, Zhang, Juanjuan, Li, Fuchun, Yu, Yanyan, Chen, Yinghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559300/
https://www.ncbi.nlm.nih.gov/pubmed/31115495
http://dx.doi.org/10.3892/ijmm.2019.4205
_version_ 1783425807680536576
author Li, Panpan
Zhang, Juanjuan
Li, Fuchun
Yu, Yanyan
Chen, Yinghong
author_facet Li, Panpan
Zhang, Juanjuan
Li, Fuchun
Yu, Yanyan
Chen, Yinghong
author_sort Li, Panpan
collection PubMed
description Recently, the use of low-intensity ultrasound (LIUS) combined with chemotherapeutic agents is widely used in clinical practice, mainly for the treatment of cancer; however, the mechanisms as to how LIUS enhances the antitumor effects of these agents are not fully understood. The aim of the present study was to explore the synergistic antitumor effects and mechanisms of cisplatin (DDP) combined with LIUS (LIUS-DDP) in hepatocellular carcinoma (HCC). We reported that LIUS effectively enhanced Huh7 and HCCLM3 cell sensitivity to a low concentration of DDP. Reverse transcription-quantitative polymerase chain reaction analysis revealed that LIUS could increase the expression of microRNA-34a (miR-34a) in HCC cells following DDP treatment. In addition, LIUS-DDP significantly increased intracellular reactive oxygen species (ROS) levels in vitro, and the upregulation of miR-34a induced by LIUS-DDP was reversed by the ROS scavenger N-acetylcysteine, suggesting that LIUS upregulates the expression of miR-34a via production of ROS. In addition, knockdown of miR-34a in HCC cells significantly suppressed the synergistic effects of LIUS-DDP treatment. Conversely, overexpression of miR-34a enhanced these synergistic effects. The results of a dual-luciferase assay indicated that c-Met, a well-known oncogene, was a target of miR-34a. We also determined that LIUS-DDP treatment inhibited the expression of c-Met, possibly due to increased ROS production, which upregulated miR-34a expression. Furthermore, overexpression of c-Met reversed the synergistic effects of LIUS-DDP treatment. Our findings suggest that LIUS could enhance the chemosensitivity of HCC cells to DDP by altering the miR-34a/c-Met axis. Therefore, DDP combined with LIUS may be a potential therapeutic application for the clinical treatment of patients with HCC.
format Online
Article
Text
id pubmed-6559300
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-65593002019-06-12 Low-intensity ultrasound enhances the chemosensitivity of hepatocellular carcinoma cells to cisplatin via altering the miR-34a/c-Met axis Li, Panpan Zhang, Juanjuan Li, Fuchun Yu, Yanyan Chen, Yinghong Int J Mol Med Articles Recently, the use of low-intensity ultrasound (LIUS) combined with chemotherapeutic agents is widely used in clinical practice, mainly for the treatment of cancer; however, the mechanisms as to how LIUS enhances the antitumor effects of these agents are not fully understood. The aim of the present study was to explore the synergistic antitumor effects and mechanisms of cisplatin (DDP) combined with LIUS (LIUS-DDP) in hepatocellular carcinoma (HCC). We reported that LIUS effectively enhanced Huh7 and HCCLM3 cell sensitivity to a low concentration of DDP. Reverse transcription-quantitative polymerase chain reaction analysis revealed that LIUS could increase the expression of microRNA-34a (miR-34a) in HCC cells following DDP treatment. In addition, LIUS-DDP significantly increased intracellular reactive oxygen species (ROS) levels in vitro, and the upregulation of miR-34a induced by LIUS-DDP was reversed by the ROS scavenger N-acetylcysteine, suggesting that LIUS upregulates the expression of miR-34a via production of ROS. In addition, knockdown of miR-34a in HCC cells significantly suppressed the synergistic effects of LIUS-DDP treatment. Conversely, overexpression of miR-34a enhanced these synergistic effects. The results of a dual-luciferase assay indicated that c-Met, a well-known oncogene, was a target of miR-34a. We also determined that LIUS-DDP treatment inhibited the expression of c-Met, possibly due to increased ROS production, which upregulated miR-34a expression. Furthermore, overexpression of c-Met reversed the synergistic effects of LIUS-DDP treatment. Our findings suggest that LIUS could enhance the chemosensitivity of HCC cells to DDP by altering the miR-34a/c-Met axis. Therefore, DDP combined with LIUS may be a potential therapeutic application for the clinical treatment of patients with HCC. D.A. Spandidos 2019-07 2019-05-21 /pmc/articles/PMC6559300/ /pubmed/31115495 http://dx.doi.org/10.3892/ijmm.2019.4205 Text en Copyright: © Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Li, Panpan
Zhang, Juanjuan
Li, Fuchun
Yu, Yanyan
Chen, Yinghong
Low-intensity ultrasound enhances the chemosensitivity of hepatocellular carcinoma cells to cisplatin via altering the miR-34a/c-Met axis
title Low-intensity ultrasound enhances the chemosensitivity of hepatocellular carcinoma cells to cisplatin via altering the miR-34a/c-Met axis
title_full Low-intensity ultrasound enhances the chemosensitivity of hepatocellular carcinoma cells to cisplatin via altering the miR-34a/c-Met axis
title_fullStr Low-intensity ultrasound enhances the chemosensitivity of hepatocellular carcinoma cells to cisplatin via altering the miR-34a/c-Met axis
title_full_unstemmed Low-intensity ultrasound enhances the chemosensitivity of hepatocellular carcinoma cells to cisplatin via altering the miR-34a/c-Met axis
title_short Low-intensity ultrasound enhances the chemosensitivity of hepatocellular carcinoma cells to cisplatin via altering the miR-34a/c-Met axis
title_sort low-intensity ultrasound enhances the chemosensitivity of hepatocellular carcinoma cells to cisplatin via altering the mir-34a/c-met axis
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559300/
https://www.ncbi.nlm.nih.gov/pubmed/31115495
http://dx.doi.org/10.3892/ijmm.2019.4205
work_keys_str_mv AT lipanpan lowintensityultrasoundenhancesthechemosensitivityofhepatocellularcarcinomacellstocisplatinviaalteringthemir34acmetaxis
AT zhangjuanjuan lowintensityultrasoundenhancesthechemosensitivityofhepatocellularcarcinomacellstocisplatinviaalteringthemir34acmetaxis
AT lifuchun lowintensityultrasoundenhancesthechemosensitivityofhepatocellularcarcinomacellstocisplatinviaalteringthemir34acmetaxis
AT yuyanyan lowintensityultrasoundenhancesthechemosensitivityofhepatocellularcarcinomacellstocisplatinviaalteringthemir34acmetaxis
AT chenyinghong lowintensityultrasoundenhancesthechemosensitivityofhepatocellularcarcinomacellstocisplatinviaalteringthemir34acmetaxis